VOOZH about

URL: https://pubmed.ncbi.nlm.nih.gov/32956786/

⇱ Potential sources, modes of transmission and effectiveness of prevention measures against SARS-CoV-2 - PubMed


Clipboard, Search History, and several other advanced features are temporarily unavailable.
Skip to main page content
πŸ‘ Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

πŸ‘ Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Abstract

During the current SARS-CoV-2 pandemic new studies are emerging daily providing novel information about sources, transmission risks and possible prevention measures. In this review, we aimed to comprehensively summarize the current evidence on possible sources for SARS-CoV-2, including evaluation of transmission risks and effectiveness of applied prevention measures. Next to symptomatic patients, asymptomatic or pre-symptomatic carriers are a possible source with respiratory secretions as the most likely cause for viral transmission. Air and inanimate surfaces may be sources; however, viral RNA has been inconsistently detected. Similarly, even though SARS-CoV-2 RNA has been detected on or in personal protective equipment (PPE), blood, urine, eyes, the gastrointestinal tract and pets, these sources are currently thought to play a negligible role for transmission. Finally, various prevention measures such as handwashing, hand disinfection, face masks, gloves, surface disinfection or physical distancing for the healthcare setting and in public are analysed for their expected protective effect.

Keywords: SARS-CoV-2; epidemiology; prevention; sources; transmission.

PubMed Disclaimer

References

    1. Saglietto A., D'Ascenzo F., Zoccai G.B., De Ferrari G.M. COVID-19 in Europe: the Italian lesson. Lancet. 2020;395:1110–1111. - PMC - PubMed
    1. WHO . WHO; 2020. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. Interim guidance. 19 March 2020.
    1. Cole E.C., Cook C.E. Characterization of infectious aerosols in health care facilities: an aid to effective engineering controls and preventive strategies. Am J Infect Control. 1998;26:453–464. - PMC - PubMed
    1. Joynt G.M., Wu W.K. Understanding COVID-19: what does viral RNA load really mean? Lancet Infect Dis. 2020 doi: 10.1016/s1473-3099(20)30237-1. - DOI - PMC - PubMed
    1. Zou L., Ruan F., Huang M., Liang L., Huang H., Hong Z., et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382:1177–1179. - PMC - PubMed
Cite

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.